Shares of Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) surged as much as 27% on Friday, a day after the company announced that it has received approval from the U.S. Food and Drug...(
read more)
EpiCept Corporation (NASDAQ: EPCT) on Monday announced that it received a refusal to file letter from the U.S. Food and Drug Administration (FDA) on the New Drug Application (NDA) for...(
read more)
Recently, Cumberland Pharmaceuticals Inc. (CPIX) announced results from a meta-analysis comparing the safety and efficacy of Caldolor (ibuprofen)...(
read more)